168
Participants
Start Date
October 31, 2015
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
ABT-122
Injection
Site Reference ID/Investigator# 138959, Budapest
Site Reference ID/Investigator# 138928, Sofia
Site Reference ID/Investigator# 138930, Sofia
Site Reference ID/Investigator# 138929, Sofia
Site Reference ID/Investigator# 138986, Auckland
Site Reference ID/Investigator# 138925, Plovdiv
Site Reference ID/Investigator# 138926, Plovdiv
Site Reference ID/Investigator# 138927, Plovdiv
Site Reference ID/Investigator# 138922, Woolloongabba
Site Reference ID/Investigator# 138987, Newtown, Wellington
Site Reference ID/Investigator# 138988, Nelson
Site Reference ID/Investigator# 139020, Santiago de Compostela
Site Reference ID/Investigator# 138953, Lübeck
Site Reference ID/Investigator# 141365, Frankfurt
Site Reference ID/Investigator# 138932, Uherské Hradiště
Site Reference ID/Investigator# 139016, Targu-Mures, Jud. Mures
Site Reference ID/Investigator# 138934, Prague
Site Reference ID/Investigator# 138933, Prague
Site Reference ID/Investigator# 138983, Ādaži
Site Reference ID/Investigator# 138985, Riga
Site Reference ID/Investigator# 138982, Riga
Site Reference ID/Investigator# 138984, Valmiera
Site Reference ID/Investigator# 139000, Bialystok
Site Reference ID/Investigator# 139012, Bydgoszcz
Site Reference ID/Investigator# 138999, Elblag
Site Reference ID/Investigator# 139007, Katowice
Site Reference ID/Investigator# 139006, Krakow
Site Reference ID/Investigator# 139005, Lublin
Site Reference ID/Investigator# 139026, Oświęcim
Site Reference ID/Investigator# 139004, Poznan
Site Reference ID/Investigator# 139001, Stalowa Wola
Site Reference ID/Investigator# 139011, Szczecin
Site Reference ID/Investigator# 139003, Torun
Site Reference ID/Investigator# 139010, Wroclaw
Site Reference ID/Investigator# 139013, Bucharest
Site Reference ID/Investigator# 139022, Elche
Lead Sponsor
AbbVie
INDUSTRY